- Title
- Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
- Creator
- Chen, Dongqing; Untaru, Rossana; Stavropoulou, Glykeria; Assadi-Khansari, Bahador; Kelly, Conagh; Croft, Amanda J.; Sugito, Stuart; Collins, Nicholas J.; Sverdlov, Aaron L.; Ngo, Doan T. M.
- Relation
- Journal of Clinical Medicine Vol. 12, Issue 8, no. 2790
- Publisher Link
- http://dx.doi.org/10.3390/jcm12082790
- Publisher
- MDPI AG
- Resource Type
- journal article
- Date
- 2023
- Description
- The role of soluble suppression of tumorigenicity (sST2) as a biomarker in predicting clinical outcomes in patients with cardiovascular diseases (CVD) has not been fully elucidated. In this study, we sought to determine the relationship between sST2 levels and any unplanned hospital readmissions due to a major adverse cardiovascular event (MACE) within 1 year of first admission. Patients (n = 250) admitted to the cardiology unit at John Hunter Hospital were recruited. Occurrences of MACE, defined as the composite of total death, myocardial infarction (MI), stroke, readmissions for heart failure (HF), or coronary revascularization, were recorded after 30, 90, 180, and 365 days of first admission. On univariate analysis, patients with atrial fibrillation (AF) and HF had significantly higher sST2 levels vs. those who did not. Increasing levels of sST2 by quartiles were significantly associated with AF, HF, older age, low hemoglobin, low eGFR, and high CRP levels. On multivariate analysis: high sST2 levels and diabetes remained as risk predictors of any MACE occurrence; an sST2 level in the highest quartile (Q4: >28.4 ng/mL) was independently associated with older age, use of beta-blockers, and number of MACE events within a 1 year period. In this patient cohort, elevated sST2 levels are associated with unplanned hospital admission due to MACE within 1 year, independent of the nature of the index cardiovascular admission.
- Subject
- biomarker; soluble suppression of tumorigenicity (sST2); major adverse cardiovascular event (MACE); cardiovascular; outcomes; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1493257
- Identifier
- uon:53520
- Identifier
- ISSN:2077-0383
- Rights
- x
- Language
- eng
- Reviewed
- Hits: 921
- Visitors: 917
- Downloads: 0
Collections
Goal 3: Good Health and Well-Being
| Thumbnail | File | Description | Size | Format |
|---|